Suppression of miR-29 protects against cardiac fibrosis

Stefan Engelhardt (right) and Petros Avramopoulos: researchers at TUM’s In
Stefan Engelhardt (right) and Petros Avramopoulos: researchers at TUM’s Institute of Pharmacology and Toxicology have investigated the effects of miR-29. (image: Heddergott / TUM)
Research news

Cardiac fibrosis involves an increase of connective tissue in the cardiac muscle, causing a loss of function. A team of researchers at the Technical University of Munich (TUM) has now discovered that microRNA 29 (miR-29) plays an important role in the formation of tissue fibrosis. They occur less frequently when miR-29 is suppressed in cardiac muscle cells. Older studies had suggested that it was in fact low levels of miR-29 that caused fibrosis. The new insights point to potential new approaches for developing drugs against fibrotic diseases.


Not long ago, microRNAs were not even known to exist. In recent years, however, it has become increasingly clear that these molecules play an important role in the function of our cells. ...
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.